Merck to acquire Prometheus in a US$ 10.8 b deal, page-89

Just scroll back the charts on many stocks to around March 2020 when Covid was recognised as a major issue. Serious drops for pretty much everything. Things then bounced back and more for the good ones. Trying to decide how to handle these situations is near impossible though, in large part because the response isn't likely to be rational, particularly early on. Something to be said for not overextending and being able to hold through a rough patch and take advantage of opportunities where good companies have been oversold.

The above concerns negative hard to foresee factors. Their possible impact would suggest you're better off being cautious and taking profits asap. On the other side is that in the not too far off future Neuren could possibly attract a solid takeover offer at a significant premium. What to do?!?! I'm hoping the latter predates the former.